Eiger BioPharmaceuticals doses first patients with Lambda in COVID-19 trial
Eiger BioPharmaceuticals said that it has dosed the first patients in a phase 2 trial of its hepatitis delta virus drug candidate peginterferon lambda (Lambda) ... Read More
Trio Pharmaceuticals, Aji Bio-Pharma to co-develop antibody drug conjugates
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) have entered into a development collaboration agreement to assess AJICAP, a site-specific conjugation technology offered by the ... Read More
Verndari begins preclinical testing of COVID-19 vaccine candidate
Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. ... Read More
CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials
US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development of its COVID-19 drug candidate GP1681 into ... Read More
Citius seeks FDA nod for evaluating stem cell therapy for ARDS in COVID-19
Citius Pharmaceuticals has made a Pre-IND submission to the US Food and Drug Administration for a novel stem cell therapy for acute respiratory distress syndrome ... Read More
Innovent Biologics begins parsaclisib phase 2 trial in follicular lymphoma
Innovent Biologics has dosed the first patient in a phase 2 trial of parsaclisib (IBI-376), a novel and selective PI3Kδ inhibitor in follicular lymphoma (FL). ... Read More
COVID-19 RT-PCR detection kit : Fosun Pharma secures FDA EUA status
Shanghai Fosun Pharmaceutical (Fosun Pharma) has been granted the emergency use authorization (EUA) status for its COVID-19 RT-PCR detection kit from the US Food and Drug ... Read More
GS COVID-19RT-PCR diagnostic test : GenoSensor secures FDA EUA status
COVID-19 diagnostic test : GenoSensor has been granted emergency use authorization status from the US Food and Drug Administration (FDA) for its GS COVID-19 real-time ... Read More
Takeda Pharmaceutical to sell OTC and non-core products to Orifarm
Japan-based Takeda Pharmaceutical has agreed to sell a portfolio of 110 non-core over-the-counter (OTC) and prescription pharmaceutical products it sells in Europe along with a ... Read More
SARS-CoV-2 vaccine trial : Sinovac Biotec begins COVID-19 vaccine candidate human trial
SARS-CoV-2 vaccine trial : Chinese biopharma company Sinovac Biotech has started a phase 1 clinical trial for SARS-CoV-2 vaccine, its COVID-19 vaccine candidate in 144 ... Read More